UV Flu Technologies hires vp of sales

The move will accelerate product development and enhancement plans

UV Flu Technologies, a US developer of biotechnology products initially targeting the indoor air quality industry sector, has hired Denny Mulloy as executive vice president of sales, marketing and alliances for UV Flu, and its subsidiary, Rx Air.

Mulloy has a long career in various senior sales and marketing positions with companies such as NCR, Xerox, Dun and Bradstreet and I2 Technologies. He has recently been serving as chief operating partner for Blue Green Partners, a green technology and services company located in Dallas, Texas.

“Denny's addition will enable us to efficiently address our newly created demand and growth opportunities. This strategic decision will accelerate our new product development, and enhancement plans,” said Jack Lennon, president of UV Flu.

You may also like

Regulatory

UV Flu Technologies launches RX Air Plus

Brings together RX-3000 and ViraTech UV-400 technologies that kill more than 99% of bacteria
Regulatory

UV Flu Technologies buys RxAir Industries

Expands air purification equipment range
Regulatory

UV Flu Tech to buy industrial air purifier manufacturer

Highest-volume product is based on HEPA equipment
Design & Build

UV Flu Technologies makes first sale in France

Takes order for 50 ViraTech UV 400 units
Sustainability

Micronclean secures Silver EcoVadis rating for sustainability performance

The cleanroom services provider ranks in the top 15% of companies assessed globally for ESG practices
Regulatory

Extract Technology fully integrates into Dec Group and unveils new company name

Dec Group UK reflects unified vision and strengthened capabilities for global customers
Design & Build

Deadline is approaching to submit applications for FDA’s PreCheck Pilot Program for pharma industries

The US Food and Drug Administration has opened applications for a scheme to give pharmaceutical manufacturers early guidance for developing new facilities, which will close on March 1
Subscribe now